Search - tctmd.com

Displaying 1 - 20 of 85

Sort: Relevancy | Date

News CV Team Pro

The Emory Healthcare Cath Lab Teams

L.A. McKeown

December 18, 2019

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

L.A. McKeown

October 29, 2019

News Daily News

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

Todd Neale

October 18, 2019

News Daily News

Drug Abuse in Infective Endocarditis Patients Spikes Amid US Opioid Epidemic

Caitlin E. Cox

October 02, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

News Conference News ESC 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

L.A. McKeown

September 05, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

Advertisement

The Emory Healthcare Cath Lab Teams

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

Drug Abuse in Infective Endocarditis Patients Spikes Amid US Opioid Epidemic

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

TCT 2019 Day Two: Transcatheter Valves, New and Old

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

Aborted TAVR Procedures Are Waning in the US

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content